LEADER 01214nas 2200445- 450 001 9910367658103321 005 20240604074232.0 011 $a2632-2498 035 $a(DE-599)ZDB3009682-0 035 $a(OCoLC)1096470535 035 $a(CKB)4970000000101785 035 $a(CONSER)--2019243240 035 $a(NjHacI)994970000000101785 035 $a(EXLCZ)994970000000101785 100 $a20190408a20199999 o-- - 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNeuro-oncology advances 210 1$a[Oxford] :$cOxford University Press,$d[2019]- 215 $a1 online resource 517 1 $aNOA 531 10$aNeurooncol Adv 606 $aBrain$xCancer 606 $aBrain$xCancer$vPeriodicals 608 $aPeriodical. 608 $aPeriodicals.$2fast 615 0$aBrain$xCancer. 615 0$aBrain$xCancer 676 $a616.99481 712 02$aSociety for Neuro-Oncology, 712 02$aEuropean Association of NeuroOncology, 801 0$bNjHacI 801 1$bNjHacl 906 $aJOURNAL 912 $a9910367658103321 996 $aNeuro-oncology advances$92048119 997 $aUNINA